[HTML][HTML] Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes
L Chen, J Zhu, Y Li, J Lu, L Gao, H Xu, M Fan, X Yang - PLoS One, 2013 - journals.plos.org
The design of optimized nanoparticles offers a promising strategy to enable DNA vaccines to
cross various physiological barriers for eliciting a specific and protective mucosal immunity …
cross various physiological barriers for eliciting a specific and protective mucosal immunity …
Ligand-appended BBB-targeted nanocarriers (LABTNs)
Delivering therapeutics across the blood brain barrier (BBB) remains the rate-limiting step in
brain medicine research. Three main categories of endogenous transportation at BBB that …
brain medicine research. Three main categories of endogenous transportation at BBB that …
Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages
We evaluated the influence of ligand grafting on the rate and intensity of uptake of poly (d, l-
lactide-co-glycolide) microparticles by alveolar macrophages. Microspheres with a mean …
lactide-co-glycolide) microparticles by alveolar macrophages. Microspheres with a mean …
Short-term biocompatibility of biphasic nanocolloids with potential use as anisotropic imaging probes
Advances in nanotechnology, in particular the development of novel types of nanoparticles,
will result in advanced tools for biomedical research and clinical practice. One exciting …
will result in advanced tools for biomedical research and clinical practice. One exciting …
Biomedical applications of magnetic nanoparticles
A Wu, P Ou, L Zeng - Nano, 2010 - World Scientific
In this review, the applications of magnetic nanoparticles in biomedicine are summarized
and introduced in three parts.(1) A short description of magnetic nanoparticles is …
and introduced in three parts.(1) A short description of magnetic nanoparticles is …
[HTML][HTML] Surface-anchored poly (acryloyl-L (D)-valine) with enhanced chirality-selective effect on cellular uptake of gold nanoparticles
J Deng, S Wu, M Yao, C Gao - Scientific Reports, 2016 - nature.com
Chirality is one of the ubiquitous phenomena in biological systems. The left handed (L-)
amino acids and right handed (D-) sugars are normally found in proteins and in RNAs and …
amino acids and right handed (D-) sugars are normally found in proteins and in RNAs and …
Visualization of internalization of functionalized cobalt ferrite nanoparticles and their intracellular fate
VB Bregar, J Lojk, V Šuštar, P Veranič… - International journal of …, 2013 - Taylor & Francis
In recent years, nanoparticles (NPs) and related applications have become an intensive
area of research, especially in the biotechnological and biomedical fields, with magnetic …
area of research, especially in the biotechnological and biomedical fields, with magnetic …
A novel luminescent bifunctional POSS as a molecular platform for biomedical applications
A novel luminescent polyhedral oligomeric silsesquioxane (POSS) containing in the
structure a fluorescein derivative molecule and a carboxylic functionality, suitable to anchor …
structure a fluorescein derivative molecule and a carboxylic functionality, suitable to anchor …
Influence of surface coating of PLGA particles on the internalization and functions of human endothelial cells
D Yu, Y Zhang, X Zhou, Z Mao, C Gao - Biomacromolecules, 2012 - ACS Publications
This study is focused on the uptake of PLGA particles with different coatings and its
influences on the functions and toxicity of human endothelial cells. The PLGA particles …
influences on the functions and toxicity of human endothelial cells. The PLGA particles …
pH-responsive polysaccharide-based polyelectrolyte complexes as nanocarriers for lysosomal delivery of therapeutic proteins
MI Giannotti, O Esteban, M Oliva… - …, 2011 - ACS Publications
Nanopharmaceutics composed of a carrier and a protein have the potential to improve the
activity of therapeutical proteins. Therapy for lysosomal diseases is limited by the lack of …
activity of therapeutical proteins. Therapy for lysosomal diseases is limited by the lack of …